Israel - hebraisk - Ministry of Health

rafa laboratories ltd - terbinafine hydrochloride - קרם - terbinafine hydrochloride 1 % - terbinafine - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. t. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidemophyton floccosum. yeast infections of the skin, principally those caused by the genus candida (e.g. candida albicans). pityriasis (tinea versicolor due to pityrosporum orbiculare (also known as malassezia furfur).

Israel - hebraisk - Ministry of Health

thomas&thomas medical - אחות - סט ומיכל להזלפת אינסולין

Israel - hebraisk - Ministry of Health

"טבע מדיקל (שיווק) בע""מ" - אחות - אביזרים רפואיים

Israel - hebraisk - Ministry of Health

ביומטריקס - אחות - מחברים ללא מחט להכנת ומתן תרופות ציטוטוקסיו ת

Israel - hebraisk - Ministry of Health

sanofi israel ltd - amiodarone hydrochloride - תמיסה להזרקה - amiodarone hydrochloride 50 mg / 1 ml - amiodarone - amiodarone - corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.

Israel - hebraisk - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 8000 iu / 0.8 ml - erythropoietin

Israel - hebraisk - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii

Israel - hebraisk - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii

Israel - hebraisk - Ministry of Health

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.

Israel - hebraisk - Ministry of Health

novartis israel ltd - tisagenlecleucel - tisagenlecleucel